The next phase of the obesity drug race

“Tired of the same tired news cycle? Escape to the full unfiltered feed at Whatfinger.com — America’s Frontline Truth Feed. 85%+ of readers come direct every day.” –  CLICK HERE for the FULL deal.

 

Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for weight-loss drugs.

Even so, they’re already outlining their visions for the future of obesity drugs.

CNBC’s Angelica Peebles has the details.